News

ADI team members from across the globe met up in Xi'an China in late October 2024 for the 27th Asia-Pacific Region Conference of Alzheimer’s Disease International and the 2024 Annual Conference of Alzheimer’s Disease Chinese. This blog showcases highlights from the conferences and the ADI Asia Pacific regional meeting.

The creation of the World Alzheimer Report is always a dynamic and collaborative process. This year’s report is a follow-up to the 2019 World Alzheimer Report on attitudes to dementia, and like five years ago, ADI commissioned the London School of Economics’ Care Policy and Evaluation Centre The survey and report aimed to track changes in global perceptions of dementia, while adding new questions around treatments and policy impact. Hear from ADI’s Publications Manager Chloé Benoist about how the team brought this year’s report together.

In October, ADI engaged in crucial discussions and events across Europe, emphasizing the importance of addressing dementia as a public health priority through innovative strategies and global collaboration.

In a regional push for improved dementia support, Kazakhstan's first Dementia Awareness Day highlights the progress being made across Central and Western Asia. In this blog we spotlight the work being undertaken in the region.

ADI is sharing a snapshot of the Asia Pacific region’s activities during World Alzheimer’s Month this year. From memory walks, to dementia screenings, to concerts, ADI has been delighted to see such a broad variety of activities dedicated to raising awareness of dementia in the region.  With opening words from ADI’s Regional Director for Asia Pacific, we are reporting the multiple actions and efforts that have been taken across the region.

As the World Alzheimer’s Month 2024 campaign draws to close, ADI is proud to report on this year’s achievements from our global community as we united to focus on the urgent message: "Time to act on dementia." With over 81 million global impressions and 4,000 mentions in the media, the campaign brought together dementia associations, advocates, professionals, and carers to raise awareness and reduce stigma to hold events worldwide, including memory walks, exhibitions, presentations, and illuminated landmarks that highlighted the importance of addressing dementia stigma. To all that have taken part, we would like to say thank you for another World Alzheimer’s Month filled with global action.

ADI is sharing a round-up of the recent activities in the Americas region during this year’s World Alzheimer’s Month. Our member associations in the Americas have showcased their collective strength in the region while making strides in both their dementia awareness-raising efforts as well as their support for those who have been impacted by dementia and their carers.  

The UK medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing authorisation for lecanemab in the treatment of early Alzheimer’s disease. However, the treatment will not be available through the National Health Service (NHS), the UK’s publicly funded health agency.